How do you approach continuing versus deprescribing long-term proton pump inhibitors in patients with severe corpus atrophy/GIM and numerous fundic gland polyps? Does the presence of advanced atrophy/GIM change your threshold to stop or step down therapy or switch class of acid-suppressive medication?